Khosla Ventures Acquisition Co.

NasdaqCM:KVSA Stock Report

Market Cap: US$74.3m

Khosla Ventures Acquisition Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Samir Kaul

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.9yrs

Recent management updates

Recent updates

SPAC Khosla Ventures gains on report of deal to take Valo Health public

Jun 09

CEO

Samir Kaul (49 yo)

2.9yrs

Tenure

Mr. Samir Kaul, M.B.A. is a Director at Valo Health, Inc. from November, 2021. He served as Director of Vicarious Surgical Inc. (Formerly, D8 Holdings Corp.) since September 2021 until October 18, 2022. He...


Board Members

NamePositionTenureCompensationOwnership
Samir Kaul
President2.9yrsno datano data
Molly Coye
Independent Director2.9yrsno data0.58%
$ 429.6k
Mario Schlosser
Independent Director2.9yrsno data0.58%
$ 429.6k
Rajiv Shah
Independent Director2.9yrsno data0.58%
$ 429.6k
Dmitri Shklovsky
Independent Director2.9yrsno data0.58%
$ 429.6k

2.9yrs

Average Tenure

49yo

Average Age

Experienced Board: KVSA's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.